Data / Form D filings / Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc.: Form D filings
Mid-Atlantic BioTherapeutics, Inc., a biotechnology company in Doylestown, PA, filed 2 Form D notices with the SEC between 2018 and 2024. The latest, on September 30, 2024, reports an offering of $5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3805 OLD EASTON ROAD, Doylestown, PA, 18902
- Phone
- (215) 266-2301
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1755678
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Oct 11, 2018 | New notice | $10,000,000 | $875,000 | $9,125,000 | 1 | Jun 28, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Julian Chick | Director | |
| David Horn | Executive Officer, Director | |
| Michael Goldblatt | Director | |
| Andrew Katz | Director | |
| David Jobes | Executive Officer, Director | |
| Jean Pierre Gagnon | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Sep 30, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mid-Atlantic BioTherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.